# Catheter Evaluation for Endocardial Ablation in Patients With Typical Atrial Flutter

> **NCT00318565** · PHASE4 · COMPLETED · sponsor: **Biosense Webster, Inc.** · enrollment: 291 (actual)

## Conditions studied

- Atrial Flutter

## Interventions

- **DEVICE:** RF energy delivery for treatment of Typical Atrial flutter

## Key facts

- **NCT ID:** NCT00318565
- **Lead sponsor:** Biosense Webster, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2007-09
- **Final completion:** 2008-02
- **Target enrollment:** 291 (ACTUAL)
- **Last updated:** 2012-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00318565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00318565, "Catheter Evaluation for Endocardial Ablation in Patients With Typical Atrial Flutter". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00318565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*